tiprankstipranks
BioMarin Pharmaceutical (GB:0HNC)
LSE:0HNC
UK Market

BioMarin Pharmaceutical (0HNC) Technical Analysis

2 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
BioMarin Pharmaceutical’s (0HNC) Moving Averages Convergence Divergence (MACD) indicator is 0.64, suggesting BioMarin Pharmaceutical is a Buy.
BioMarin Pharmaceutical’s (0HNC) 20-Day exponential moving average is 59.67, while BioMarin Pharmaceutical’s (0HNC) share price is $61.33, making it a Buy.
BioMarin Pharmaceutical’s (0HNC) 50-Day exponential moving average is 58.31, while BioMarin Pharmaceutical’s (0HNC) share price is $61.33, making it a Buy.

BioMarin Pharmaceutical (0HNC) Pivot Points

Aug 07, 2026, 02:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
58.28
59.24
59.72
60.68
61.16
62.12
62.60
Fibonacci
59.24
59.79
60.13
60.68
61.23
61.57
62.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioMarin Pharmaceutical (0HNC) Moving Averages

Aug 07, 2026, 02:31 PM
Period
Simple
Exponential
MA5
60.00Sell
60.07Sell
MA10
60.38Sell
60.06Sell
MA20
59.75Sell
59.67Buy
MA50
58.02Buy
58.31Buy
MA100
56.13Buy
57.34Buy
MA200
56.47Buy
56.78Buy
BioMarin Pharmaceutical’s (0HNC) 10-Day exponential moving average is 60.06, while BioMarin Pharmaceutical’s (0HNC) share price is $61.33, making it a Sell.
BioMarin Pharmaceutical’s (0HNC) 100-Day exponential moving average is 57.34, while BioMarin Pharmaceutical’s (0HNC) share price is $61.33, making it a Buy.
BioMarin Pharmaceutical’s (0HNC) stock price is $61.33 and BioMarin Pharmaceutical’s (0HNC) 50-day simple moving average is 58.02, creating a Buy signal.
BioMarin Pharmaceutical’s (0HNC) stock price is $61.33 and BioMarin Pharmaceutical’s (0HNC) 100-day simple moving average is 56.13, creating a Buy signal.
BioMarin Pharmaceutical’s (0HNC) stock price is $61.33 and BioMarin Pharmaceutical’s (0HNC) 200-day simple moving average is 56.47, creating a Buy signal.

BioMarin Pharmaceutical (0HNC) Technical Indicators

Aug 07, 2026, 02:31 PM
Name
Value
Implied Action
RSI (14)
52.39
Neutral
STOCH (9,6)
34.45
Neutral
STOCHRSI (14)
46.98
Neutral
MACD (12,26)
0.64
Buy
ADX (14)
29.04
Neutral
Williams %R
-61.48
Buy
CCI (14)
18.04
Neutral
ATR (14)
1.61
-
Ultimate Oscillator
34.73
Neutral
ROC
-0.18
Sell
BioMarin Pharmaceutical’s (0HNC) Relative Strength Index (RSI) is 52.39, creating a Neutral signal.
BioMarin Pharmaceutical’s (0HNC) Trend Strength Indicator (ADX) is 29.04, creating a Neutral signal.
BioMarin Pharmaceutical’s (0HNC) Commodity Channel Index (CCI) is 18.04, creating a Neutral signal.
BioMarin Pharmaceutical’s (0HNC) Price Rate of Change (ROC) is -0.18, creating a Sell signal.

FAQ

Is 0HNC a Buy, Hold, or Sell?
Based on 0HNC’s technical indicators, 0HNC is a Buy.
    What is 0HNC’s RSI (14)?
    0HNC’s RSI (14) is 52.39, which suggests 0HNC is a Neutral.
      What is 0HNC’s MACD?
      0HNC’s MACD is 0.64, which suggests 0HNC is a Buy.
        What is 0HNC’s 5-day moving average?
        0HNC’s 5-day moving average is 60.00, which suggests 0HNC is a Sell.
          What is 0HNC’s 20-day moving average?
          0HNC 20-day moving average is 59.75, which suggests 0HNC is a Sell.
            What is 0HNC’s 50-day moving average?
            0HNC’s 50-day moving average is 58.02, which suggests 0HNC is a Buy.
              What is 0HNC’s 200-day moving average?
              0HNC’s 200-day moving average is 56.47, which suggests 0HNC is a Buy.
                What is 0HNC’s Williams % R (14)?
                0HNC’s Williams % R (14) is -61.48, which suggests 0HNC is a Buy.
                  What is 0HNC’s CCI (14)?
                  0HNC’s CCI (14) is 18.04, which suggests 0HNC is a Neutral.
                    What is the share price of BioMarin Pharmaceutical?